Table 1.
Age-adjusted prevalence according to MetS definition within NHANES cohorts.
| N | ATPIII 2001 | ATPIII revised | WHO | IDF | |
|---|---|---|---|---|---|
| NHANES 1988-1994 [143] | 8,814 | 23.7% | |||
| NHANES 1988-1994 [144] | 8,608 | 23.9% | 25.1% | ||
| NHANES 1988-1994 [145] | 6,436 | 24.1% | 29.2% | ||
| NHANES 1999-2002 [145] | 1,677 | 27.0% | 32.3% | ||
| NHANES 1999-2002 [10] | 3,601 | 34.6% | 39.1% | ||
| NHANES 2003-2006 [13] | 3,423 | 34% | |||
ATPIII = National Cholesterol Education Program Adult Treatment Panel III; IDF = International Diabetes Federation; MetS = metabolic syndrome; NHANES = National Health and Examination Survey; WHO = World Health Organization.